Urate-lowering therapy adherence and the association with medication beliefs, self-efficacy, depression, anxiety, and COVID-19 pandemic-related concern in Chinese gout patients: a cross-sectional study

References

• Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84(2), 191–215. https://doi.org/10.1037/0033-295X.84.2.191
   PubMed Web of Science ®Google Scholar
• Chua, X., Lim, S., Lim, F. P., Lim, Y., He, H. G., & Teng, G. G. (2018). Factors influencing medication adherence in patients with gout: A descriptive correlational study. Journal of Clinical Nursing, 27(1–2), e213–e222. https://doi.org/10.1111/jocn.13918
   PubMed Web of Science ®Google Scholar
• Coburn, B. W., Bendlin, K. A., Sayles, H., Hentzen, K. S., Hrdy, M. M., & Mikuls, T. R. (2016). Target serum urate: Do gout patients know their goal? Arthritis Care & Research, 68(7), 1028–1035. https://doi.org/10.1002/acr.22785
   Web of Science ®Google Scholar
• Corbett, E. J. M., Pentony, P., & Mcgill, N. W. (2017). Achieving serum urate targets in gout: An audit in a gout‐oriented rheumatology practice. International Journal of Rheumatic Diseases, 20(7), 894–897. https://doi.org/10.1111/1756-185X.13032
   PubMed Web of Science ®Google Scholar
• Dalbeth, N., Petrie, K. J., House, M., Chong, J., Leung, W., Chegudi, R., Horne, A., Gamble, G., Mcqueen, F. M., & Taylor, W. J. (2011). Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care & Research, 63(11), 1605–1612. https://doi.org/10.1002/acr.20570
   Web of Science ®Google Scholar
• De Achaval, S., & Suarez-Almazor, M. E. (2010). Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International Journal of Clinical Rheumatology, 5(3), 313–326. https://doi.org/10.2217/ijr.10.15
   PubMedGoogle Scholar
• Dehlin, M., Jacobsson, L., & Roddy, E. (2020). Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors. Nature Reviews: Rheumatology, 16(7), 380–390. https://doi.org/10.1038/s41584-020-0441-1
   PubMed Web of Science ®Google Scholar
• De Klerk, E., van der Heijde, D., van der Tempel, H., & van der Linden, S. (1999). Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. The Journal of Rheumatology, 26(12), 2635–2641.
   PubMed Web of Science ®Google Scholar
• Deng, S. Q., & Peng, H. J. (2020 2). Characteristics of and public health responses to the coronavirus disease 2019 outbreak in china. Journal of Clinical Medicine, 9(2), 575. https://doi.org/10.3390/jcm9020575
   PubMed Web of Science ®Google Scholar
• Fu, T., Cao, H., Yin, R., Zhang, L., Zhang, Q., Li, L., Feng, X., & Gu, Z. (2017). Depression and anxiety correlate with disease-related characteristics and quality of life in Chinese patients with gout: a case-control study. Psychology, Health & Medicine, 23(4), 400–410. http://doi.org/10.1080/13548506.2017.1378819
   PubMed Web of Science ®Google Scholar
• Harrold, L. R., Andrade, S. E., Briesacher, B., Raebel, M. A., Fouayzi, H., Yood, R. A., & Ockene, I. S. (2010). The dynamics of chronic gout treatment: Medication gaps and return to therapy. The American Journal of Medicine, 123(1), 54–59. https://doi.org/10.1016/j.amjmed.2009.05.026
   PubMed Web of Science ®Google Scholar
• Harrold, L. R., Mazor, K. M., Velten, S., Ockene, I. S., & Yood, R. A. (2010). Patients and providers view gout differently: A qualitative study. Chronic Illness, 6(4), 263–271. https://doi.org/10.1177/1742395310378761
   PubMedGoogle Scholar
• Horne, R., & Weinman, J. (1999). Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47(6), 555–567. https://doi.org/10.1016/s0022-39999900057-4
   PubMed Web of Science ®Google Scholar
• Howren, A., Bowie, D., Choi, H. K., Rai, S. K., & De Vera, M. A. (2021). Epidemiology of Depression and Anxiety in Gout: A Systematic Review and Metaanalysis. The Journal of Rheumatology, 48(1), 129–137. http://doi.org/10.3899/jrheum.190974
   PubMed Web of Science ®Google Scholar
• Leclair, T., Carret, A. S., Samson, Y., Sultan, S., & Phillips, R. S. (2016). Stability and repeatability of the Distress Thermometer (DT) and the Edmonton Symptom Assessment System-Revised (ESAS-r) with parents of childhood cancer survivors. PLoS One, 11(7), e159773. https://doi.org/10.1371/journal.pone.0159773
   PubMed Web of Science ®Google Scholar
• Lee, S., & So, M. W. (2016). Adherence with urate-lowering therapies among male patients with gout in a routine clinical setting. Modern Rheumatology / the Japan Rheumatism Association, 26(6), 950–955. https://doi.org/10.3109/14397595.2016.1170914
   PubMed Web of Science ®Google Scholar
• Lemay, J., Waheedi, M., Al-Sharqawi, S., & Bayoud, T. (2018). Medication adherence in chronic illness: Do beliefs about medications play a role? Patient Preference and Adherence, 12, 1687–1698. https://doi.org/10.2147/PPA.S169236
   PubMed Web of Science ®Google Scholar
• Lorig, K. R., Sobel, D. S., Ritter, P. L., Laurent, D., & Hobbs, M. (2001). Effect of a self-management program on patients with chronic disease. Effective Clinical Practice: ECP, 4(6), 256–262.
   PubMedGoogle Scholar
• Mcculley, C., Katz, P., Trupin, L., Yelin, E. H., & Barton, J. L. (2018). Association of medication beliefs, self-efficacy, and adherence in a diverse cohort of adults with rheumatoid arthritis. The Journal of Rheumatology, 45(12), 1636. https://doi.org/10.3899/jrheum.171339
   PubMed Web of Science ®Google Scholar
• Onder, G., Rezza, G., & Brusaferro, S. (2020). Case-Fatality rate and characteristics of patients dying in relation to COVID-19 in italy. JAMA. https://doi.org/10.1001/jama.2020.4683
   Google Scholar
• Osterberg, L., & Blaschke, T. (2005). Adherence to medication. The New England Journal of Medicine, 353(5), 487–497. http://doi.org/10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Salt, E., & Frazier, S. K. (2010). Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A narrative review of the literature. Orthopaedic Nursing / National Association of Orthopaedic Nurses, 29(4), 260–275. https://doi.org/10.1097/NOR.0b013e3181e5c2c9
   PubMed Web of Science ®Google Scholar
• Scheepers, L. E. J. M., van Onna, M., Stehouwer, C. D. A., Singh, J. A., Arts, I. C. W., & Boonen, A. (2018). Medication adherence among patients with gout: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 47(5), 689–702. https://doi.org/10.1016/j.semarthrit.2017.09.007
   PubMed Web of Science ®Google Scholar
• Singh, J. A. (2014a). Challenges faced by patients in gout treatment: A qualitative study. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases, 20(3), 172–174. https://doi.org/10.1097/RHU.0000000000000091
   PubMed Web of Science ®Google Scholar
• Singh, J. A. (2014b). Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: A qualitative study. Arthritis Research & Therapy, 16(2), R82. https://doi.org/10.1186/ar4524
   PubMed Web of Science ®Google Scholar
• Spencer, K., Carr, A., & Doherty, M. (2012). Patient and provider barriers to effective management of gout in general practice: A qualitative study. Annals of the Rheumatic Diseases, 71(9), 1490–1495. https://doi.org/10.1136/annrheumdis-2011-200801
   PubMed Web of Science ®Google Scholar
• Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders: Patient Health Questionnaire. JAMA, 282(18), 1737–1744. https://doi.org/10.1001/jama.282.18.1737
   PubMed Web of Science ®Google Scholar
• Spitzer, R. L., Kroenke, K., Williams, J. B., & Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092
   PubMed Web of Science ®Google Scholar
• Spruill, T. M., Ogedegbe, G., Harrold, L. R., Potter, J., Scher, J. U., Rosenthal, P. B., & Greenberg, J. D. (2014). Association of medication beliefs and self-efficacy with adherence in urban Hispanic and African–American rheumatoid arthritis patients. Annals of the Rheumatic Diseases, 73(1), 317–318. https://doi.org/10.1136/annrheumdis-2013-203560
   PubMed Web of Science ®Google Scholar
• Tencent News. 2022. Real-time tracking of COVID-19. https://news.qq.com/zt2020/page/feiyan.htm#/3/17/2022
   Google Scholar
• Uhlig, T., Karoliussen, L. F., Sexton, J., Kvien, T. K., Haavardsholm, E. A., Perez-Ruiz, F., & Hammer, H. B. (2022). Fluctuation and change of serum urate levels and flares in gout: Results from the NOR-Gout study. Clinical Rheumatology, 41(12), 3817–3823. https://doi.org/10.1007/s10067-022-06416-4
   PubMed Web of Science ®Google Scholar
• Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected Pneumonia in Wuhan, China. JAMA, 323(11), 1061. https://doi.org/10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2022. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int/17/3/2022
   Google Scholar
• Yin, R., Cao, H., Fu, T., Zhang, Q., Zhang, L., Li, L., & Gu, Z. (2017). The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: A cross-sectional study. Rheumatology International, 37(7), 1187–1194. https://doi.org/10.1007/s00296-017-3746-x
   PubMed Web of Science ®Google Scholar
• Yin, R., Li, L., Zhang, G., Cui, Y., Zhang, L., Zhang, Q., Fu, T., Cao, H., Li, L., & Gu, Z. (2018). Rate of adherence to urate-lowering therapy among patients with gout: A systematic review and meta-analysis. British Medical Journal Open, 8(4), e17542. https://doi.org/10.1136/bmjopen-2017-017542
   PubMed Web of Science ®Google Scholar